Australia Stock Exchange release from GENETIC SIGNATUR : 3base SARS-CoV-2 kit registered by TGA for saliva samples
09/01/2022 23:32
Australia Stock Exchange release from GENETIC SIGNATUR GSS.AX : 3base SARS-CoV-2 kit registered by TGA for saliva samples
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing Director
Brief: Genetic Signatures Logs Q3 Sales A$3 Mln
Australia's Genetic Signatures extends gain on deal with Danish hospital
Australia's Genetic Signatures jumps on supply agreement with Denmark hospital
Brief: Genetic Signatures Signs Danish Supply Agreement